v3.24.2.u1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Non-controlling Interest
Beginning balance (in shares) at Jan. 31, 2023   235,777        
Beginning balance at Jan. 31, 2023 $ 1,487,434 $ 118 $ 2,612,705 $ (1,148,163) $ (1,019) $ 23,793
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of options (in shares)   585        
Issuance of common stock upon exercise of options 4,125   4,125      
Issuance of common stock under RSU and PSU release (in shares)   1,944        
Issuance of common stock under employee stock purchase plan (in shares)   450        
Issuance of common stock under employee stock purchase plan 45,432 $ 1 45,431      
Issuance of common stock for founders holdbacks related to acquisitions (in shares)   18        
Issuance of common stock for founders holdbacks related to acquisitions 2,538   2,538      
Issuance of common stock for payment of board of director fees (in shares)   1        
Issuance of common stock for payment of board of director fees 167   167      
Stock-based compensation expense, net of founder revest 292,941   292,941      
Capitalized stock-based compensation 18,468   18,468      
Net income 8,975     8,963   12
Non-controlling interest 8,088         8,088
Other comprehensive income (loss) 1,932       1,932  
Ending balance (in shares) at Jul. 31, 2023   238,775        
Ending balance at Jul. 31, 2023 1,870,100 $ 119 2,976,375 (1,139,200) 913 31,893
Beginning balance (in shares) at Apr. 30, 2023   237,099        
Beginning balance at Apr. 30, 2023 1,634,359 $ 118 2,752,716 (1,147,672) 139 29,058
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of options (in shares)   210        
Issuance of common stock upon exercise of options 1,474   1,474      
Issuance of common stock under RSU and PSU release (in shares)   1,011        
Issuance of common stock under employee stock purchase plan (in shares)   450        
Issuance of common stock under employee stock purchase plan 45,432 $ 1 45,431      
Issuance of common stock for founders holdbacks related to acquisitions (in shares)   5        
Issuance of common stock for founders holdbacks related to acquisitions 889   889      
Issuance of common stock for payment of board of director fees 88   88      
Stock-based compensation expense, net of founder revest 163,811   163,811      
Capitalized stock-based compensation 11,966   11,966      
Net income 8,476     8,472   4
Non-controlling interest 2,831         2,831
Other comprehensive income (loss) 774       774  
Ending balance (in shares) at Jul. 31, 2023   238,775        
Ending balance at Jul. 31, 2023 1,870,100 $ 119 2,976,375 (1,139,200) 913 31,893
Beginning balance (in shares) at Jan. 31, 2024   241,865        
Beginning balance at Jan. 31, 2024 $ 2,337,089 $ 121 3,364,328 (1,058,836) (1,663) 33,139
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of options (in shares) 300 300        
Issuance of common stock upon exercise of options $ 2,464   2,464      
Issuance of common stock under RSU and PSU release (in shares)   2,434        
Issuance of common stock under RSU and PSU release 0 $ 2 (2)      
Issuance of common stock under employee stock purchase plan (in shares)   518        
Issuance of common stock under employee stock purchase plan 56,099 $ 0 56,099      
Issuance of common stock for founders holdbacks related to acquisitions (in shares)   5        
Issuance of common stock for founders holdbacks related to acquisitions 1,778   1,778      
Issuance of common stock for payment of board of director fees 175   175      
Stock-based compensation expense, net of founder revest 380,109   380,109      
Capitalized stock-based compensation 19,478   19,478      
Fair value of replacement equity awards attributable to pre-acquisition service 468   468      
Net income 92,954     89,833   3,121
Non-controlling interest 1,415         1,415
Other comprehensive income (loss) (1,439)       (1,439)  
Ending balance (in shares) at Jul. 31, 2024   245,122        
Ending balance at Jul. 31, 2024 2,890,590 $ 123 3,824,897 (969,003) (3,102) 37,675
Beginning balance (in shares) at Apr. 30, 2024   243,184        
Beginning balance at Apr. 30, 2024 2,568,782 $ 122 3,556,194 (1,016,016) (4,760) 33,242
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of options (in shares)   208        
Issuance of common stock upon exercise of options 1,641   1,641      
Issuance of common stock under RSU and PSU release (in shares)   1,210        
Issuance of common stock under RSU and PSU release 0 $ 1 (1)      
Issuance of common stock under employee stock purchase plan (in shares)   518        
Issuance of common stock under employee stock purchase plan 56,099   56,099      
Issuance of common stock for founders holdbacks related to acquisitions (in shares)   2        
Issuance of common stock for founders holdbacks related to acquisitions 889   889      
Issuance of common stock for payment of board of director fees 87   87      
Stock-based compensation expense, net of founder revest 198,476   198,476      
Capitalized stock-based compensation 11,512   11,512      
Net income 46,690     47,013   (323)
Non-controlling interest 4,756         4,756
Other comprehensive income (loss) 1,658       1,658  
Ending balance (in shares) at Jul. 31, 2024   245,122        
Ending balance at Jul. 31, 2024 $ 2,890,590 $ 123 $ 3,824,897 $ (969,003) $ (3,102) $ 37,675